Heart gene therapy trial begins
5 September 2013 Last updated at 19:40 BST
A ground-breaking gene therapy trial for patients with damaged hearts has begun in at a London hospital.
The treatment uses a genetically modified virus, which contains instructions to produce a protein that heart failure patients are lacking in their heart muscle.
Heart failure affects more than 750,000 people in the UK.
Fergus Walsh reports.